Abstract
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have